A phase II single arm study of Nivolumab with stereotactic Ablative radiation Therapy after induction chemotherapy in CHOlangiocarcinoma (NATCHO).
Charbel EliasYoussef H ZeidanYoussef BouferraaDeborah MukherjiSally TemrazMaya CharafeddineMonita Al DaraziAli ShamseddinePublished in: BMC cancer (2022)
ClinicalTrials.gov NCT04648319 , April 20, 2018.